It is uncertain if patients coinfected with hepatitis C and HIV are more likely to suffer fulminant hepatic failure (FHF) when compared to patients with HIV-only.
Dr Kramerab and colleagues from Texas, America undertook a study of a cohort from national administrative databases from the Department of Veterans Affairs in patients hospitalized for the first time with HIV and/or hepatitis C between 10/1991 and 9/2000.
The researchers defined fulminant hepatic failure as occurring after the index hospitalization through 9/2001 in the absence of pre-existing liver disease.
The research team calculated incidence rates, Kaplan Meier cumulative incidence curves, and Cox proportional hazards ratios while adjusting for demographics and other potential confounders.
The researchers identified 11,678 patients with HIV-only and 4761 patients with coinfection.
|Cumulative incidence of fulminant hepatic failure in the coinfected group was higher than in the HIV-only group|
|Journal of Hepatology|
The research team noted that there were 92 cases of fulminant hepatic failure yielding an incidence rate of 1.1/1000 person-years and 2.5/1000 person-years in the HIV-only and coinfected groups.
The researchers found that the cumulative incidence of fulminant hepatic failure in the coinfected group was higher than in the HIV-only group.
In addition, the research team noted that the risk of fulminant hepatic failure in patients with coinfection compared to HIV-only during the HAART era was several folds higher than that during the pre-HAART era.
Dr Kramerab concluded, "HAART and hepatitis C coinfection appeared to act synergistically in HIV-infected patients to increase the risk of fulminant hepatic failure, a rare but often fatal disease."